Your browser doesn't support javascript.
loading
Structural and biochemical analysis of 1-Cys peroxiredoxin ScPrx1 from Saccharomyces cerevisiae mitochondria.
Li, Chang-Cheng; Yang, Mei-Jia; Yang, Jing; Kang, Mei; Li, Tao; He, Li-Hui; Song, Ying-Jie; Zhu, Yi-Bo; Zhao, Ning-Lin; Zhao, Chang; Huang, Qin; Mou, Xing-Yu; Li, Hong; Tong, Ai-Ping; Tang, Hong; Bao, Rui.
Affiliation
  • Li CC; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Yang MJ; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Yang J; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Kang M; Department of Laboratory medicine, West, China Hospital, Sichuan University.
  • Li T; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • He LH; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Song YJ; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Zhu YB; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Zhao NL; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Zhao C; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Huang Q; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Mou XY; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Li H; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Tong AP; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Tang H; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center.
  • Bao R; Center of Infectious Diseases, State Key Laboratory of Biotherapy, West, China Hospital, Sichuan University and Collaborative Innovation Center. Electronic address: baorui@scu.edu.cn.
Biochim Biophys Acta Gen Subj ; 1864(12): 129706, 2020 12.
Article in En | MEDLINE | ID: mdl-32805320
ABSTRACT

BACKGROUND:

ScPrx1 is a yeast mitochondrial 1-Cys peroxiredoxins (Prx), a type of Prx enzyme which require thiol-containing reducing agents to resolve its peroxidatic cysteine. ScPrx1 plays important role in protection against oxidative stress. Mitochondrial thioredoxin ScTrx3 and glutathione have been reported to be the physiological electron donor for ScPrx1. However, the mechanism underlying their actions, especially the substrate recognition of ScPrx1 requires additional elucidation.

METHODS:

The structure of ScPrx1 was obtained through crystallization experiments. The oligomeric state of ScPrx1 was monitored by Blue-Native PAGE. Mutations were generated by the QuikChange PCR-based method. The ScPrx1 activity assay was carried out by measuring the change of 340 nm absorption of the NADPH oxidation.

RESULTS:

ScPrx1 exist as a homodimer in solution. The structure adopts a typical Prx-fold core which is preceded by an N-terminal ß-hairpin and has a C-terminal extension. Mutations (Glu94Ala, Arg198Ala and Trp126) close to the active site could enhance the catalytic efficiency of ScPrx1 while His83Ala and mutations on α4-ß6 region exhibited reduced activity. The biochemical data also show that the deletion or mutations on ScPrx1 C-terminal have 2-4.56 fold increased activity.

CONCLUSION:

We inferred that conformational changes of ScPrx1 C-terminal segment were important for its reaction, and the α4-ß6 loop regions around the ScPrx1 active sites were important for the catalytic function of ScPrx1. Collectively, these structural features provides a basis for understanding the diverse reductant species usage in different 1-Cys Prxs.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peroxidases / Saccharomyces cerevisiae / Saccharomyces cerevisiae Proteins Language: En Journal: Biochim Biophys Acta Gen Subj Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peroxidases / Saccharomyces cerevisiae / Saccharomyces cerevisiae Proteins Language: En Journal: Biochim Biophys Acta Gen Subj Year: 2020 Document type: Article
...